Biotech

All Articles

Ionis centers eye ailment from intendeds of Roche-partnered possibility after records disappoint

.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has actually disappointed assumptions...

Biogen's chief executive officer claimed no dangerous handle 2023. He's ready to be daring

.While Biogen's pharma peers are actually seeking for late-stage possessions with little risk, CEO C...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been a biotech trying to find a pipe after it ditched its own lead pr...

Biogen leaves Denali Alzheimer's collab

.Biogen has handed back liberties to a very early Alzheimer's illness system to Denali Rehabs, going...

Takeda water faucets new mind people oncology company-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings ...

Vertex, hammered through AATD again, falls 2 resources on dispose of stack

.Vertex's try to manage an unusual hereditary ailment has actually hit an additional trouble. The bi...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter profits file had not been except major updates. The business acc...

Galapagos pauses CAR-T cell therapy litigation over Parkinsonism scenario

.Galapagos has stopped enrollment in a trial of a BCMA-directed CAR-T cell treatment, pushing the br...

James Wilson leaving behind Penn to introduce pair of new biotechs

.After greater than thirty years, genetics treatment trailblazer James Wilson M.D., Ph.D., is leavin...

3 biotechs try to trump the summer season warmth by losing staff

.As biotechs try to transform a fresh web page in August, at least three business have actually drop...